On Thursday, ZBB Energy Corporation (NYSEMKT:ZBB)’s shares gained 13.43%, and closed at $0.76.
Last Tuesday, ZBB Energy Corporation, declared the successful third party validation of its breakthrough Agile Flow Battery specifically designed for behind the meter energy storage applications in the commercial and industrial building market. The independent third party validation was performed at one of the world’s top battery and grid power control products testing facilities, in Beijing, China. The Agile Flow Battery has been engineered based upon ZBB’s industry leading flow battery design expertise, its breadth of real world application data derived from dozens of installations, and stringent lab testing at ZBB and Meineng Energy, ZBB’s China joint venture corporation. The Agile Flow Battery enables a large amount of energy to be deployed from a relatively small footprint, and is designed for the lowest life cycle cost accessible for applications requiring more than 2 hours of discharged energy.
The commercial validation of the Agile Flow Battery by an independent 3rd party was the culmination of a product development program that began in July 2014 and utilized concurrent engineering, procurement, assembly and testing between ZBB Energy and Meineng Energy. The validation measured a large number of performance parameters, counting maximum capacity, rated capacity, on-line self-discharge, safety, efficiency, and state of charge accuracy. The Agile Flow Battery met or exceeded performance targets for the product, counting a rated energy capacity of 55.7kWh vs. target of 50kWh at rated charge of 16.5kW and rated discharge of 12.5kW. Maximum energy capacity was more than 57kWh. The battery notably delivered 46.9kWh of energy after 12 hours of operating in idle mode with pumps, motors and fans being on and electrolyte circulating, exhibiting excellent on-line self-discharge performance. Maximum state of charge inaccuracy over the 0-100-0% charge/discharge cycle was 3.15% and 0.73% on average. Cycle to cycle energy discharge variability was a very repeatable ~0.5kWh, max-min. The DC efficiency of the eight battery arrays in the Agile were measured at an average of ~75%. Safety parameters of noise and hydrogen evolution were also measured, both passing local safety specifications. Noise was < 71dB one meter from the battery while operating. Peak hydrogen evolution inside the battery cabinet was 0% of the lower explosive limit (LEL) and was 13% of LEL inside the tanks during 18 hours of running, well under the 25% government specification of 25% of LEL.
ZBB Energy Corporation develops, licenses, manufactures, and sells distributed energy storage solutions based upon the proprietary zinc bromide rechargeable electrical energy storage technology and proprietary power electronics systems in the United States and internationally. It provides advanced electrical power administration platforms for distributed renewable energy, energy efficiency, power quality, and grid modernization.
Gevo, Inc. (NASDAQ:GEVO)’s shares jumped 13.41%, and settled at $0.19, during the last trading session on Thursday.
Formerly on March 26, Gevo, Inc., declared its financial results for the three months ended December 31, 2014 and offered an update on recent corporate highlights.
In the fourth quarter of 2014, Gevo continued to progress the commercial operation of isobutanol at Luverne under the Side-by-Side mode of production (SBS), meeting its stated milestone in December 2014 of producing greater than fifty thousand gallons of isobutanol in one month. This achievement was a result of the introduction of Gevo’s second-generation yeast biocatalyst at the plant, in addition to noteworthy process improvements learned by Gevo since switching the plant to SBS production earlier in 2014, along with the development of key segments of the isobutanol market, with a focus on those where renewable isobutanol performance attributes solve customer problems. Brenntag Canada began sales of isobutanol to the specialty chemical markets, while Gulf Racing Fuels began introducing isobutanol for use in off-road applications, counting sales to retail consumers through NAPA Auto Parts in North Dakota.
Gevo’s hydrocarbons business continued to show progress, with strengthening demand being shown for the jet fuel, isooctane and paraxylene derived from isobutanol produced at Luverne. Certain parties have shown interest in offtake contracts for these products, and Gevo anticipates achieving both ASTM (American Society for Testing and Materials) and MIL-SPEC (Defense Specification) certifications for its jet fuel in 2015, which would assist accelerate the commercial adoption of Gevo’s product in both the commercial and military jet markets.
To augment the planned interest in this hydrocarbons business segment, Gevo declared the introduction of a new technology it has developed to convert ethanol into a tailored mix of end-products, counting propylene (an ingredient in consumer plastics, fibers, films, and superabsorbants) and renewable hydrogen. Preliminary technical and economic analyses indicate that the products, sourced from renewable feedstock, would be cost competitive with traditional petrochemical approaches. Following successful scale-up, we believe this technology would open up a much broader set of end-product market and margin opportunities for ethanol producers.
Gevo, Inc., a renewable chemicals and biofuels corporation, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.
At the end of Thursday’s trade, OvaScience, Inc. (NASDAQ:OVAS)’s shares climbed 12.55%, and closed at $35.06.
Formerly on March 28, OvaScience, Inc., declared additional clinical experience of the Corporation’s AUGMENTSM treatment demonstrated improved pregnancy rates in women who had failed three to seven preceding in vitro fertilization (IVF) cycles. These results were stated at the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting being held in San Francisco, CA. The AUGMENT treatment is not accessible in the United States.
The results stated in the poster presentation represent experiences from a small number of patients with different diagnoses, ages and preceding IVF history. As of this reporting, pregnancy rates across IVF clinics that offer the AUGMENT treatment presently range from 25% - 53%, which comprises clinics that are treating some of the more challenging infertility patients. OvaScience is collecting AUGMENT patient experience in a first-of-its-kind international registry, and anticipates sharing information from a broader patient experience when it is accessible.
“The positive clinical evidence continues to build in support of our AUGMENT treatment,” stated Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience. “These improved pregnancy rates in women who have failed IVF multiple times, coupled with similar encouraging clinical AUGMENT experiences at other IVF clinics, provide physicians and patients with important information about how the AUGMENT treatment may improve egg health in women with infertility.”
OvaScience, Inc., a life science corporation, engages in the discovery, development, and commercialization of new treatments for infertility. The corporation’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman’s own ovaries.
China Ming Yang Wind Power Group Limited (NYSE:MY), ended its Thursday’s trading session with 10.79% gain, and closed at $2.67.
Formerly on March 25, China Ming Yang Wind Power Group Limited, took 8th in world’s top 10 wind turbine original equipment manufacturers ranking in 2014, raised from 9th last year, according to the report of Global Wind Turbine OEM Market Share Study released by MAKE Consulting. The same source reveals that the market share of Ming Yang hit 9.9% in total in 2014, with an 11.1% increase of the whole market growth. Ming Yang was also one of the only two Chinese companies that retained its position compared to 2013.
The report also shows that 8 out of the 15 world’s top OEMs in 2014 were from China. “China’s unparalleled growth dominates the industry,” cited the report, which says the Chinese wind market grew 23.6GW in 2014, reaching 114.9GW in total.
China Ming Yang Wind Power Group Limited designs, manufactures, sells, and services megawatt-class wind turbines in the People’s Republic of China and the Republic of India.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
